Company Filing History:
Years Active: 2007
Title: Isabelle Cartier: Innovator in Cervical Health
Introduction
Isabelle Cartier is a prominent inventor based in Paris, France. She has made significant contributions to the field of cervical health through her innovative research and patented methods. Her work focuses on predicting the outcomes of cervical intra-epithelial neoplasia, a critical area in women's health.
Latest Patents
Isabelle Cartier holds a patent for "Methods and compositions for predicting the outcome of cervical intra-epithelial neoplasia." This invention relates to methods and kits designed to predict the outcome of cervical intra-epithelial neoplasia. More specifically, the methods involve determining the presence of the HLA-DRB1*13 allele and the absence of high-risk human papillomavirus (HPV). She has 1 patent to her name.
Career Highlights
Isabelle works at the prestigious Institut Curie, where she collaborates with leading experts in cancer research. Her dedication to advancing medical science has positioned her as a key figure in her field.
Collaborations
Isabelle collaborates with Xavier Sastre-Garau, a fellow researcher at Institut Curie. Their partnership enhances the research efforts in cervical health and contributes to the development of innovative solutions.
Conclusion
Isabelle Cartier's work exemplifies the impact of innovation in healthcare, particularly in women's health. Her contributions are vital for improving the understanding and treatment of cervical intra-epithelial neoplasia.